Department of Pathology, City of Hope National Medical Center, Duarte, CA 91010, USA.
Am J Surg Pathol. 2013 Mar;37(3):453-8. doi: 10.1097/PAS.0b013e31828446d6.
Mast cell sarcoma (MCS) is an extremely rare neoplasm with a clinically aggressive course. Because of its rarity, its morphologic and molecular characteristics are still not well defined. We report a case of a 15-year-old girl with MCS of the temporal bone extending into the posterior fossa creating a mass effect. The lesion mimicked a histiocytic neoplasm morphologically, but showed a novel KIT missense mutation, L799F (2395 C>T). The KIT D816V mutation is frequently found in systemic mastocytosis, but it has not been documented in the few reported human MCS cases. However, 1 reported case of MCS has shown a different alteration in the KIT gene. Our case is the first MCS case with L799F mutation, located between the catalytic loop (790 to 797) and the activation loop (810 to 837) of the KIT gene, and only the second case of MCS with KIT mutation documented in the literature. Proximity of the L799F mutation to the enzymatic region of the KIT tyrosine kinase domain may induce resistance to tyrosine kinase inhibitors.
肥大细胞瘤肉瘤(MCS)是一种极其罕见的具有临床侵袭性病程的肿瘤。由于其罕见性,其形态和分子特征仍未得到很好的定义。我们报告了一例 15 岁女孩的颞骨 MCS 延伸至后颅窝,产生肿块效应。病变在形态上类似于组织细胞肿瘤,但显示出一种新的 KIT 错义突变,L799F(2395C>T)。KIT D816V 突变在系统性肥大细胞增多症中经常发现,但在少数报道的人类 MCS 病例中尚未记录。然而,有 1 例 MCS 报告显示 KIT 基因发生了不同的改变。我们的病例是首例 L799F 突变的 MCS 病例,位于 KIT 基因的催化环(790 至 797)和激活环(810 至 837)之间,也是文献中第二例有 KIT 突变记录的 MCS 病例。L799F 突变靠近 KIT 酪氨酸激酶结构域的酶区域,可能诱导对酪氨酸激酶抑制剂的耐药性。